Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Malar J. 2020 Feb 11;19(1):68. doi: 10.1186/s12936-020-3149-4.
Malaria is major public health concerns which continues to claim the lives of more than 435,000 people each year. The challenges with anti-malarial drug resistance and detection of low parasitaemia forms an immediate barrier to achieve the fast-approaching United Nations Sustainable Development Goals of ending malaria epidemics by 2030. In this Opinion article, focusing on the recent published technologies, in particularly the nuclear magnetic resonance (NMR)-based diagnostic technologies, the authors offer their perspectives and highlight ways to bring these point-of-care technologies towards personalized medicine. To this end, they advocate an open sourcing initiative to rapidly close the gap between technological innovations and field implementation.
疟疾是一个重大的公共卫生关注点,每年仍有超过 43.5 万人因此失去生命。抗疟药物耐药性的挑战以及对低寄生虫血症形式的检测,立即构成了实现联合国 2030 年消除疟疾流行的可持续发展目标的障碍。在这篇观点文章中,作者重点关注了最近发表的技术,特别是基于核磁共振(NMR)的诊断技术,提出了他们的观点,并强调了将这些即时检测技术推向个性化医疗的方法。为此,他们主张采取开源倡议,以迅速缩小技术创新与现场实施之间的差距。